Veeva R&D and Quality Summit Connect

One day of virtual learning and connecting with industry experts

Last year over 5,000 leaders and experts joined us at Veeva Summit Online to learn and connect with the industry.

Registration is now open for 2021 Veeva R&D and Quality Summit Connect.

This year’s virtual Summit brings a fresh approach with a new one-day agenda focused on connecting you with fellow industry leaders to learn the latest trends in life sciences.

At Veeva Summit Connect, you’ll see the latest innovations, best practices, and learn what’s coming next in clinical operations, clinical data, quality, regulatory, and safety.

Access is complimentary for Veeva customers and other professionals in the biopharmaceutical industry.

Why Attend? Infographic

Hear What Past Summit Attendees Have Said

“The virtual Summit was great. I haven’t missed a Summit since they began and looking forward to live Summits again soon as I can’t wait to see you and all my friends there at Veeva in person again and hopefully soon!”

“Summit was great like previous ones. I am a regular attendee for all of the Veeva Summits (R&D and Commercial) for the past 5 years. We are working with your team and they are supporting us excellently.”

“Virtual Summit exceeded my expectations. The excellent presentations by industry leaders sparked ideas to take back to my own organization. Coupled with the announcements about the ambitious Veeva roadmap, especially My Veeva, I leave Summit upbeat and excited about opportunities to improve clinical trial operations going forwards.”

“Summit brought together real users and was extremely interactive. Plus I picked up some great ideas.”

Previous Next

Veeva R&D and Quality Summit 2020 Highlights Video

Watch Sessions On-demand

Amy Abernethy

US Food & Drug Administration

Principal Deputy Commissioner & Acting CIO

Amy P. Abernethy, M.D., Ph.D. is an oncologist and internationally recognized clinical data expert and clinical researcher. As the Principal Deputy Commissioner of Food and Drugs, Dr. Abernethy helps oversee FDA’s day-to-day functioning and directs special and high-priority cross-cutting initiatives that impact the regulation of drugs, medical devices, tobacco and food. As acting Chief Information Officer, she oversees FDA’s data and technical vision, and its execution. She has held multiple executive roles at Flatiron Health and was professor of medicine at Duke University School of Medicine, where she ran the Center for Learning Health Care and the Duke Cancer Care Research Program. Dr. Abernethy received her M.D. at Duke University, where she did her internal medicine residency, served as chief resident, and completed her hematology/oncology fellowship. She received her Ph.D. from Flinders University, her B.A. from the University of Pennsylvania, and is boarded in palliative medicine.